
-
Trump on Iran strikes: 'I may do it, I may not do it'
-
Khamenei vows Iran will never surrender
-
Bangladesh tighten grip on first Sri Lanka Test
-
England's Pope keeps place for India series opener
-
Itoje to lead Lions for first time against Argentina
-
Oil rises, stocks mixed as investors watch rates, conflict
-
Iran-Israel war: latest developments
-
Iran threatens response if US crosses 'red line': ambassador
-
Iranians buying supplies in Iraq tell of fear, shortages back home
-
UK's Catherine, Princess of Wales, pulls out of Royal Ascot race meeting
-
Rape trial of France's feminist icon Pelicot retold on Vienna stage
-
Khamenei says Iran will 'never surrender', warns off US
-
Oil prices dip, stocks mixed tracking Mideast unrest
-
How Paris's Seine river keeps the Louvre cool in summer
-
Welshman Thomas out of Tour of Switzerland as 'precautionary measure'
-
UN says two Iran nuclear sites destroyed in Israel strikes
-
South Africans welcome home Test champions the Proteas
-
Middle Age rents live on in German social housing legacy
-
Israel targets nuclear site as Iran claims hypersonic missile attack
-
China's AliExpress risks fine for breaching EU illegal product rules
-
Liverpool face Bournemouth in Premier League opener, Man Utd host Arsenal
-
Heatstroke alerts issued in Japan as temperatures surge
-
Liverpool to kick off Premier League title defence against Bournemouth
-
Meta offered $100 mn bonuses to poach OpenAI employees: CEO Altman
-
Spain pushes back against mooted 5% NATO spending goal
-
UK inflation dips less than expected in May
-
Oil edges down, stocks mixed but Mideast war fears elevated
-
Energy transition: how coal mines could go solar
-
Australian mushroom murder suspect not on trial for lying: defence
-
New Zealand approves medicinal use of 'magic mushrooms'
-
Suspects in Bali murder all Australian, face death penalty: police
-
Taiwan's entrepreneurs in China feel heat from cross-Strait tensions
-
N. Korea to send army builders, deminers to Russia's Kursk
-
Sergio Ramos gives Inter a scare in Club World Cup stalemate
-
Kneecap rapper in court on terror charge over Hezbollah flag
-
Panthers rout Oilers to capture second NHL Stanley Cup in a row
-
Nearly two centuries on, quiet settles on Afghanistan's British Cemetery
-
Iran says hypersonic missiles fired at Israel as Trump demands 'unconditional surrender'
-
Oil stabilises after surge, stocks drop as Mideast crisis fuels jitters
-
Paul Marshall: Britain's anti-woke media baron
-
Inzaghi defends manner of exit from Inter to Saudi club
-
Made in Vietnam: Hanoi cracks down on fake goods as US tariffs loom
-
Longer exposure, more pollen: climate change worsens allergies
-
Sundowns edge Ulsan in front of empty stands at Club World Cup
-
China downplayed nuclear-capable missile test: classified NZ govt papers
-
Canada needs 'bold ambition' to poach top US researchers
-
US Fed set to hold rates steady as it guards against inflation
-
Sean 'Diddy' Combs trial offers fodder for influencers and YouTubers
-
New rules may not change dirty and deadly ship recycling business
-
US judge orders Trump admin to resume issuing passports for trans Americans

Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage
WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that a third-party evaluation has confirmed key advantages for its Cellinity battery technology's use in grid-scale battery energy storage applications.
The evaluation was conducted by U.S. BESS Corporation (www.usbesscorp.com), an expert provider of advanced energy storage solutions for critical infrastructure applications spanning utilities, defense, microgrids, and heavy industry.
U.S. BESS senior technical staff performed an examination of Cellinity's design and assembly protocols, inspection of testing infrastructure, review of data from test results, and an assessment of methodologies used for performance characterization, concluding that the following performance characteristics exclusive of any auxiliary systems are supported by their observations and are reasonably representative of the current Cellinity cell's demonstrated behavior:
Open circuit voltage: > 4.2 V
Operating temperature range: from 120°C to 250°C
Energy density: > 500 Wh/kg (calculated based on active material)
Power density: > 500 mW/cm3 (maximum observed value of 1579 W/kg at 230°C)
Charge capacity: Cell can be charged to 100% of theoretical capacity
Charge/discharge efficiency: ~100%
Energy efficiency: 95% at 230°C; 87% at 120°C
Self-discharge: No measurable self-discharge observed over test durations
Thermal cycling durability: Performance unaffected after repeated cycling
U.S. BESS Corp further concluded that it is reasonable to claim that a) the cell would not experience any thermal runaway, b) materials of construction are commonly available and can be domestically sourced, c) the cell does not contain any rare earth elements, and d) cell components are fully recyclable.
A Market Ready for Disruption
The global demand for grid-scale energy storage is rapidly growing to meet the rising loads driven by artificial intelligence, decarbonization mandates, and accelerated adoption of renewables. In 2024 alone, the U.S. Energy Information Administration (www.eia.gov) reported a 66% increase in U.S. battery energy storage capacity. While lithium-ion batteries currently dominate the market, they present known challenges: fire risks from thermal runaway, efficiency losses over time, and sourcing constraints related to rare and critical minerals.
BioLargo's Cellinity battery technology (www.biolargoenergy.com) overcomes these limitations by leveraging novel materials and architecture to deliver both exceptional thermal performance and operational efficiencywithout relying on rare earth elements.
Validation Supports Commercial Pathway
The U.S. BESS report concludes: "Based on our inspection and the evidence provided, U.S. BESS finds that the Cellinity Cell demonstrates a sufficient performance profile, with strong indications of high thermal stability, efficiency, energy and power density, and material sustainability, to suggest further investment in testing and commercialization. These attributes position this technology as a potential solution for critical gaps in grid-scale energy storage markets."
Randall Moore, Chief Technology Officer at BioLargo Energy Technologies, Inc., commented, "Our work to scale up the cell design, refine manufacturing techniques, and integrate cells into a functional module for commercial scale testing is underway."
CEO, Dennis P. Calvert commented, "We do not know of any long duration energy storage technology that can match Cellinity's technical claims for cost effective performance and safety. This third-party evaluation is an important piece of the puzzle for our business plan to bring Cellinity to the world through manufacturing joint ventures. We have several of these in development with potential partners and look forward to sharing more intel about those soon."
About U.S. BESS Corp
U.S. BESS Corp is a U.S.-based company that provides energy storage solutions for a wide range of applications, including utilities, industrial needs, microgrids and defense. With decades of combined experience in battery engineering, microgrid deployment, system-level integration, and manufacturing, the company's leadership team is uniquely qualified in the battery energy storage system industry. U.S. BESS is creating the most advanced and secure battery management system and building the largest domestic battery supply in the USA.
U.S. BESS Corp Contact Information
Mark Hagedorn
CEO, U.S. BESS Corp.
503-720-9569
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
BioLargo Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
P.Silva--AMWN